Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01855620 · ClinicalTrials.gov registry record
The Effect of Body Mass Index on Etonogestrel Hormone Levels in Women Using the Single-rod Contraceptive Implant
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 52
- Enrollment target
NCT01855620 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 52 participants.
The verdict
NCT01855620 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
Study Summary
Two-thirds of young women in the United States are overweight or obese. This excess weight may affect how their body metabolizes drugs such as different birth control methods. There is a not a lot of research about how excess weight could affect the hormone levels of the contraceptive implant. Methods like the implant contain only progesterone, which is a hormone that does not increase a woman's risk of blood clot. These methods would be preferred for overweight and obese women because excess weight also increases a woman's risk of blood clot. The investigators propose a study comparing blood hormone levels of women using the implant for at least twelve months and in all weight categories. The investigators hope to show that all women, regardless of weight, will have hormone levels high enough to prevent pregnancy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2012-12 |
| Est. Completion | 2014-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01855620
The ClinicalTrials.gov registry entry for NCT01855620 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01855620 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01855620 about?
NCT01855620 is a clinical study titled "The Effect of Body Mass Index on Etonogestrel Hormone Levels in Women Using the Single-rod Contraceptive Implant". Two-thirds of young women in the United States are overweight or obese. This excess weight may affect how their body metabolizes drugs such as different birth control methods. There is a not a lot of research about how excess weight could affect the hormone levels of the contraceptive implant. Metho...
What is the current status of trial NCT01855620?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2012-12. Estimated completion is 2014-03.
Who is sponsoring clinical trial NCT01855620?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.